---
title: Johnson & Johnson–Ollin Acquisition
description: Johnson & Johnson agrees to acquire Ollin Biosciences for $2.2bn upfront, adding OLN324, a Phase 3 candidate for wet AMD and diabetic macular oedema.
image: https://visionexecutives.com/hubfs/AI-Generated%20Media/Images/Johnson%20And%20Johnson%20Acquires%20Ollin%20Biosciences.png
---

[Skip to content](https://visionexecutives.com/blog/johnson-johnson-ollin-biosciences-acquisition#main-content)

[![Vision Executives Logo](https://visionexecutives.com/hubfs/Color%20logo%20with%20white%20text.svg)](https://www.visionexecutives.com/)

- [About](https://visionexecutives.com/about-us)
- Recruitment Services
  
  Show submenu for Recruitment Services 
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [FREE Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
- Candidate Services
  
  Show submenu for Candidate Services 
  
    - [Representing You](https://visionexecutives.com/representing-you)
- [Our Vacancies](https://visionexecutives.com/vacancies)
- News & Insights
  
  Show submenu for News & Insights 
  
    - [Latest News & Articles](https://visionexecutives.com/blog)
    - [Eyewear & Optics Salary Report](https://visionexecutives.com/eyewear-optical-industry-salary-report)
    - [Optometrist & Ophthalmologist Salary Report](https://visionexecutives.com/optometrist-ophthalmologist-salary-report)
- [Contact](https://visionexecutives.com/contact-us)

Open main navigation

Close main navigation

- [About](https://visionexecutives.com/about-us)
- Recruitment Services
  
  Show submenu for Recruitment Services 
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [FREE Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
- Candidate Services
  
  Show submenu for Candidate Services 
  
    - [Representing You](https://visionexecutives.com/representing-you)
- [Our Vacancies](https://visionexecutives.com/vacancies)
- News & Insights
  
  Show submenu for News & Insights 
  
    - [Latest News & Articles](https://visionexecutives.com/blog)
    - [Eyewear & Optics Salary Report](https://visionexecutives.com/eyewear-optical-industry-salary-report)
    - [Optometrist & Ophthalmologist Salary Report](https://visionexecutives.com/optometrist-ophthalmologist-salary-report)
- [Contact](https://visionexecutives.com/contact-us)
- [EYE-INTRO Login](https://vision-executives.i-intro.net/)

[EYE-INTRO Login](https://vision-executives.i-intro.net/)

# Johnson & Johnson–Ollin Acquisition

Nov 18, 2026, 2:11:14 PM

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives)

Share: [facebook-f icon](http://www.facebook.com/share.php?u=https://visionexecutives.com/blog/johnson-johnson-ollin-biosciences-acquisition) [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://visionexecutives.com/blog/johnson-johnson-ollin-biosciences-acquisition) [twitter icon](https://twitter.com/intent/tweet?url=https://visionexecutives.com/blog/johnson-johnson-ollin-biosciences-acquisition) [pinterest-p icon](http://pinterest.com/pin/create/link/?url=https://visionexecutives.com/blog/johnson-johnson-ollin-biosciences-acquisition) [envelope icon](mailto:?body=https://visionexecutives.com/blog/johnson-johnson-ollin-biosciences-acquisition)

### Johnson& Johnson agrees to acquire Ollin Biosciences in a deal worth up to $3.3 billion.

Johnson & Johnson has agreed to acquire Ollin Biosciences for up to $2.2 billion upfront, with additional milestone payments taking the potential deal value to approximately $3.3 billion. Announced on the 16th November 2026, the proposed acquisition would add OLN324, an investigational retinal disease treatment in Phase 3 development, to Johnson & Johnson's pipeline. 

For patients, the treatment's potential lies in better disease control and possibly longer intervals between injections. These benefits remain under investigation. 

### What is Ollin Biosciences?

Founded in 2023, Ollin Biosciences is a clinical-stage biopharmaceutical company focused on acquiring and developing treatments for vision-threatening eye diseases.

Its lead programme, OLN324, is being developed for wet age-related macular degeneration, commonly called wet AMD, and diabetic macular oedema, or DME. Ollin has advanced the programme to Phase 3 development, where further clinical evidence will inform its path towards potential regulatory approval.

### What is OLN324 designed to do?

OLN324 is a bispecific antibody designed to target two pathways involved in retinal disease: vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang2).

Johnson & Johnson says its molecular design could improve control of retinal fluid and potentially allow more time between treatments. For people managing these conditions, less frequent treatment could reduce travel and time spent attending appointments, including the time family members spend accompanying them. Whether OLN324 can deliver sustained disease control with longer treatment intervals requires further clinical evidence.

### How much is the acquisition worth?

The agreement includes $2.2 billion upfront and up to approximately $1.125 billion in regulatory and commercial milestone payments. The additional payments depend on specified milestones being achieved.<https://www.investor.jnj.com/investor-news/news-details/2026/Johnson--Johnson-to-acquire-Ollin-Biosciences-and-late-stage-bispecific-antibody-with-best-in-class-potential-in-ophthalmology/default.aspx?utm_source=chatgpt.com>

Ollin says the acquisition would provide an opportunity to build on its development progress alongside Johnson & Johnson. 

### How will Phase 3 development be funded?

In its separate acquisition announcement, Johnson & Johnson outlines a funding agreement with Blackstone Life Sciences, contingent on the transaction closing.

Blackstone will provide $750 million over several years to fully fund OLN324’s Phase 3 development. In return, it will be eligible for certain regulatory and sales milestone payments and single-digit royalties. This arrangement is separate from the acquisition price. 

### When is the acquisition expected to complete?

The companies expect the transaction to close before the end of 2026, subject to applicable regulatory approvals and customary closing conditions. The announcement confirms an agreement to acquire Ollin; completion remains pending.

 

 

## Stay connected with Vision Executives.

Follow Vision Executives on LinkedIn to stay up to date with the latest eye care industry news, insights and job vacancies across ophthalmology, optometry, optical retail and medical technology.

[Follow us on LinkedIn](https://www.linkedin.com/company/vision-executives/)

## Related posts

[![](https://visionexecutives.com/hs-fs/hubfs/Ocular%20Surface%20%26%20Contact%20Lens%20Content%20Post.png?height=200&name=Ocular%20Surface%20%26%20Contact%20Lens%20Content%20Post.png)](https://visionexecutives.com/blog/johnson-johnson-medtech-discuss-patients-lifestyles)

## [Johnson & Johnson MedTech Discuss Patients Lifestyles](https://visionexecutives.com/blog/johnson-johnson-medtech-discuss-patients-lifestyles)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 Apr 25, 2024, 10:16:26 AM

👁Johnson & Johnson MedTech's peer discussion at 100% Optical delved into the impact of lifestyle...

[Read more](https://visionexecutives.com/blog/johnson-johnson-medtech-discuss-patients-lifestyles)

[![](https://visionexecutives.com/hs-fs/hubfs/AI-Generated%20Media/Images/Johnson%20%20Johnson%20Vision%20Manufacturing%20Facility%20in%20Jacksonville.png?height=200&name=Johnson%20%20Johnson%20Vision%20Manufacturing%20Facility%20in%20Jacksonville.png)](https://visionexecutives.com/blog/johnson-johnson-strengthens-its-position-across-the-vision-care-continuum)

## [Johnson & Johnson Strengthens Across the Vision Care Continuum](https://visionexecutives.com/blog/johnson-johnson-strengthens-its-position-across-the-vision-care-continuum)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 Jun 19, 2026, 3:01:15 PM

From Cataract Surgery Innovation to $1 Billion in Vision Manufacturing Investment

[Read more](https://visionexecutives.com/blog/johnson-johnson-strengthens-its-position-across-the-vision-care-continuum)

[![](https://visionexecutives.com/hs-fs/hubfs/Revenue%20Per%20Employee.png?height=200&name=Revenue%20Per%20Employee.png)](https://visionexecutives.com/blog/4-eyecare-companies-feature-in-the-top-medtech-companies-by-revenue-per-employee)

## [4 Eyecare Companies Feature in the Top MedTech Companies by Revenue Per Employee](https://visionexecutives.com/blog/4-eyecare-companies-feature-in-the-top-medtech-companies-by-revenue-per-employee)

[Vision Executives](https://visionexecutives.com/blog/author/vision-executives) 

 Dec 12, 2024, 4:12:51 PM

🔥 4 EYECARE companies feature in the 𝐓𝐨𝐩 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐛𝐲 𝐑𝐞𝐯𝐞𝐧𝐮𝐞...

[Read more](https://visionexecutives.com/blog/4-eyecare-companies-feature-in-the-top-medtech-companies-by-revenue-per-employee)

[![Vision Executives Logo](https://visionexecutives.com/hubfs/Color%20logo%20with%20white%20text.svg "Vision Executives Logo")](https://visionexecutives.com/)

Vision Executives International Ltd  
HUB26  
Hunsworth Lane

Cleckheaton  
BD19 4LN  
​United Kingdom

 

[+44 (0) 113490 0340](tel:4401134900340)

[mailto:info@visionexecutives.com](mailto:info@visionexecutives.com)   [info@visionexecutives.com](mailto:info@visionexecutives.com)  
<https://www.linkedin.com/company/vision-executives/?originalSubdomain=uk>  [Follow us on LinkedIn](https://www.linkedin.com/company/vision-executives/?originalSubdomain=uk)

- **Quick Links**
  
    - [Home](https://visionexecutives.com)
    - [About](https://visionexecutives.com/about-us)
    - [News & Insights](https://visionexecutives.com/blog)
    - [Contact us](https://visionexecutives.com/contact-us)
    - [Vacancies](https://visionexecutives.com/vacancies)
    - [Our Candidates](https://visionexecutives.com/our-candidates)
    - [Bad Hire Calculator](https://visionexecutives.com/bad-hire-calculator)
    - [FREE Job Survey](https://visionexecutives.com/free-job-survey)
    - EYE-INTRO Login
- **Services**
  
    - [Retained Recruitment](https://visionexecutives.com/retained-recruitment)
    - [Contingency Recruitment](https://visionexecutives.com/contingency-recruitment)
    - [Representing You](https://visionexecutives.com/representing-you)

<iframe class="hs-responsive-embed-iframe" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: none;" xml="lang" src="https://www.google.com/maps/embed?pb=!1m14!1m8!1m3!1d1236136.8347097263!2d-2.72842621664985!3d52.66548923511256!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x487be19725160b51%3A0xb3b9cbfc92600618!2sVision%20Executives!5e0!3m2!1sen!2suk!4v1689253568813!5m2!1sen!2suk" width="600" height="450" allowfullscreen loading="lazy" data-service="google-maps"></iframe>

---

Website designed by [Xtra Mile Marketing](https://www.xtramilemarketing.co.uk/)

Copyright © 2026, Vision Executives

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Vision Executives",
    "url" : "https://visionexecutives.com/blog/author/vision-executives"
  },
  "dateModified" : "2026-11-18T14:11:20.240Z",
  "datePublished" : "2026-11-18T14:11:14.000Z",
  "headline" : "Johnson & Johnson–Ollin Acquisition",
  "image" : [ "https://visionexecutives.com/hubfs/AI-Generated%20Media/Images/Johnson%20And%20Johnson%20Acquires%20Ollin%20Biosciences.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://visionexecutives.com/blog/johnson-johnson-ollin-biosciences-acquisition",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://visionexecutives.com/hubfs/Globals/vision%20executives%20logo.png"
    },
    "name" : "Vision Executives"
  }
}
```